The Journal of Pediatrics
Volume 135, Issue 6 , Pages 683-688, December 1999

Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia☆☆

Medical Research Council Laboratories, Fajara, The Gambia; Children’s Hospital, Hannover Medical School, Hannover, Germany; World Health Organization, Geneva, Switzerland; and London School of Hygiene and Tropical Medicine, London, United Kingdom

Received 20 October 1998; received in revised form 28 June 1999; accepted 15 July 1999.

Abstract 

Objective: To determine the frequency of later respiratory tract morbidity after respiratory syncytial virus (RSV) disease in infancy. Design: Cohort study with passive, clinic-based surveillance. Setting: Outpatient department in The Gambia. Subjects: One hundred five children admitted to the hospital with severe RSV disease (case cohort), 105 control children matched for age not admitted to the hospital during the previous RSV season (control cohort 1), and 102 control children born after the RSV season (control cohort 2). Main outcome measures: Frequencies of pneumonia, wheezing, and hospital admission with acute lower respiratory tract infection. Results: Pneumonia was more common in case children than in both control groups (adjusted incidence rate ratio [IRR, 95% CI]: 3.80 [2.73, 6.10]), as was wheezing (IRR 7.33 [3.10,17.54]), pneumonia or wheezing (IRR 3.96 [2.60, 6.04]), and admission with pneumonia or wheezing (IRR 3.40 [1.87, 6.15]). The incidence rate per 100 child-years for pneumonia in the dry season for 12-month-old children was 27 for case patients, 8.1 for control cohort 1, and 6.51 for control cohort 2. By 3 years of age, the rates had fallen to low levels in all groups. Conclusions: Pneumonia and wheezing are significantly more common in children after RSV-associated lower respiratory tract disease than in control subjects, but the incidence declines rapidly with increasing age. (J Pediatr 1999;135:683-8)

Abbreviations:  ALRI , Acute lower respiratory tract infection, MRC , Medical Research Council, RSV , Respiratory syncytial virus

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the British Medical Research Council and, for part of the time, by Wyeth-Lederle Vaccines and Pediatrics, West Henrietta, NY. Dr Weber was supported by Deutsche Forschungsgemeinschaft grant We 1379/3-1.

☆☆ Reprint requests: Martin Weber, MD, WHO/CAH, CH 1211 Geneva 27, Switzerland.

 0022-3476/99/$8.00 + 0  9/21/101634

PII: S0022-3476(99)70085-5

The Journal of Pediatrics
Volume 135, Issue 6 , Pages 683-688, December 1999